3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
9
Breast Neoplasms
9
Salivary Gland Neoplasms
2
Prostate Adenocarcinoma
2
Triple Negative Breast Neoplasms
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Sexual Dysfunctions, Psychological
1
PSA Level Greater Than Two
1
Neoplasm Metastasis
1
Hormone Sensitive Prostate Cancer
1
HER2 Negative Breast Cancer
1
Castrate Sensitive Prostate Cancer
1
Bulbo-Spinal Atrophy, X-Linked
1
Breast Neoplasms, Male
1
Anatomic Stage I Breast Cancer AJCC v8
1
Advanced Breast Cancer
1
Interventions
pertuzumab
5
Trastuzumab
5
Docetaxel
3
tucatinib
2
pyrotinib
1
atezolizumab
1
Paclitaxel
1
Neoadjuvant Therapy
1
Injections
1
Genetic Testing
1
Carboplatin
1
Capecitabine
1
Blood Specimen Collection
1
Ado-Trastuzumab Emtansine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
HER2-positive Breast Cancer
×
Goserelin
×
90 days
×
Clear all
No trials found.